Cardiovascular Management of Aortopathy in Children
Published: August 12, 2024
- Pediatric aortopathy management presents challenges due to diverse causes and limited evidence, with existing guidelines primarily tailored for adults.
- This scientific statement introduces a flexible framework that accommodates pediatric-specific needs, acknowledges the complexity of managing pediatric cases, and addresses the gap in existing literature.
- Furthermore, the statement extends its coverage to various conditions such as Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome, MYH11 variants, and FLNA mutations, providing comprehensive guidance on aspects ranging from overview to exercise considerations for each.